Drug Profile
Research programme: metabotropic glutamate receptor 2 modulators - Merck & Co
Alternative Names: mGluR2 receptor modulators – Merck & Co; positive allosteric mGluR2 receptor modulators – Merck & CoLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Merck & Co
- Class 3-ring heterocyclic compounds; Benzimidazoles; Nitriles; Oxazoles; Small molecules
- Mechanism of Action Metabotropic glutamate receptor 2 modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Schizophrenia in USA (PO)
- 26 Aug 2010 Preclinical trials in Schizophrenia in USA (PO)